News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
All Stories
News
Scribe Therapeutics plans to test cholesterol-lowering epigenetic editing therapy
January 14, 2026
Endpoints
Read Now
Press Release
Scribe Therapeutics plans to test cholesterol-lowering epigenetic editing therapy
January 14, 2026
Endpoints
Read Now
Press Release
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
Press Release
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
News
CRISPR Slashes ‘Bad Cholesterol’ Levels by 95 Percent in Early Results
November 27, 2025
Singularity Hub
Read Now
Press Release
CRISPR Slashes ‘Bad Cholesterol’ Levels by 95 Percent in Early Results
November 27, 2025
Singularity Hub
Read Now
News
Can AI take the guesswork out of CRISPR?
November 24, 2025
Drug Discovery News
Read Now
Press Release
Can AI take the guesswork out of CRISPR?
November 24, 2025
Drug Discovery News
Read Now